Article
HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease.
Journal of human genetics - 1 May 2010
Takahashi Megumi, Kimura Akinori
Abstract excerpt
Graves' disease (GD) is an autoimmune disease characterized by hyperthyroidism due to the presence of autoantibodies against thyroid-stimulating hormone receptor, which is measured as thyroid-stimulating hormone-binding inhibitory immunoglobulin (TBII). Most of the GD patients are TBII-positive, but TBII is undetectable in a proportion of GD patients. We previously reported the association of HLA-A 02 and -DPB1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
